New genomic test could spare some people with melanoma from lymph node biopsy surgery
October 22, 2025
October 22, 2025
ROCHESTER, Minnesota, Oct. 22 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
New genomic test could spare some people with melanoma from lymph node biopsy surgery
*
ROCHESTER, Minn. -- A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes -- a finding that could guide treatment decisions and help some people . . .
* * *
New genomic test could spare some people with melanoma from lymph node biopsy surgery
*
ROCHESTER, Minn. -- A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for cancer in their lymph nodes -- a finding that could guide treatment decisions and help some people . . .